HYDERABAD Feb 25 (Reuters) - Medical device maker Medtronic (MDT.N), opens new tab is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U ...

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation approach ...

In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other dividend stocks. Dividend stocks have taken a backseat in the market as technology and AI ...

The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's ...

Before taking the corner office at ViCentra, Arnold held leadership roles at Medtronic, Procept BioRobotics, Boston Scientific and Sorin Group. Most recently, he served as VP of global marketing at ...

Seventeen years before Medtronic’s recent FDA approval for the world’s first adaptive deep brain stimulation (DBS) system for Parkinson’s disease, Scott Stanslaski was just starting his work on the ...

After hours: March 21 at 7:36:05 PM EDT Loading Chart for MDT ...

After hours: March 21 at 7:36:05 PM EDT ...